Literature DB >> 22430975

Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.

Joe Latimer1, Sarah Forbes, Andrew J McBain.   

Abstract

Subeffective exposure of Staphylococcus aureus to the biocide triclosan can reportedly induce a small-colony variant (SCV) phenotype. S. aureus SCVs are characterized by low growth rates, reduced pigmentation, and lowered antimicrobial susceptibility. While they may exhibit enhanced intracellular survival, there are conflicting reports regarding their pathogenicity. The current study reports the characteristics of an SCV-like strain of S. aureus created by repeated passage on sublethal triclosan concentrations. S. aureus ATCC 6538 (the passage 0 [P0] strain) was serially exposed 10 times to concentration gradients of triclosan to generate strain P10. This strain was then further passaged 10 times on triclosan-free medium (designated strain ×10). The MICs and minimum bactericidal concentrations of triclosan for P0, P10, and ×10 were determined, and growth rates in biofilm and planktonic cultures were measured. Hemolysin, DNase, and coagulase activities were measured, and virulence was determined using a Galleria mellonella pathogenicity model. Strain P10 exhibited decreased susceptibility to triclosan and characteristics of an SCV phenotype, including a considerably reduced growth rate and the formation of pinpoint colonies. However, this strain also had delayed coagulase production, had impaired hemolysis (P < 0.01), was defective in biofilm formation and DNase activity, and displayed significantly attenuated virulence. Colony size, hemolysis, coagulase activity, and virulence were only partially restored in strain ×10, whereas the planktonic growth rate was fully restored. However, ×10 was at least as defective in biofilm formation and DNase production as P10. These data suggest that although repeated exposure to triclosan may result in an SCV-like phenotype, this is not necessarily associated with increased virulence and adapted bacteria may exhibit other functional deficiencies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430975      PMCID: PMC3370732          DOI: 10.1128/AAC.05904-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  56 in total

1.  Molecular basis of triclosan activity.

Authors:  C W Levy; A Roujeinikova; S Sedelnikova; P J Baker; A R Stuitje; A R Slabas; D W Rice; J B Rafferty
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

2.  Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney.

Authors:  Donna M Bates; Christof von Eiff; Peter J McNamara; Georg Peters; Michael R Yeaman; Arnold S Bayer; Richard A Proctor
Journal:  J Infect Dis       Date:  2003-04-30       Impact factor: 5.226

Review 3.  Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.

Authors:  Richard A Proctor; Christof von Eiff; Barbara C Kahl; Karsten Becker; Peter McNamara; Mathias Herrmann; Georg Peters
Journal:  Nat Rev Microbiol       Date:  2006-04       Impact factor: 60.633

4.  Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants.

Authors:  Frank Kipp; Barbara C Kahl; Karsten Becker; Ellen J Baron; Richard A Proctor; Georg Peters; Christof von Eiff
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis.

Authors:  M O Clements; S P Watson; R K Poole; S J Foster
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

6.  Triclosan targets lipid synthesis.

Authors:  L M McMurry; M Oethinger; S B Levy
Journal:  Nature       Date:  1998-08-06       Impact factor: 49.962

7.  Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model.

Authors:  Costi D Sifri; Andrea Baresch-Bernal; Stephen B Calderwood; Christof von Eiff
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

8.  Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.

Authors:  Eleftherios Mylonakis; Roberto Moreno; Joseph B El Khoury; Alexander Idnurm; Joseph Heitman; Stephen B Calderwood; Frederick M Ausubel; Andrew Diener
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

9.  Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis.

Authors:  B Kahl; M Herrmann; A S Everding; H G Koch; K Becker; E Harms; R A Proctor; G Peters
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

10.  Small colony variants in staphylococcal infections: diagnostic and therapeutic implications.

Authors:  R A Proctor; G Peters
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

View more
  26 in total

1.  Effects of Formulation on Microbicide Potency and Mitigation of the Development of Bacterial Insusceptibility.

Authors:  Nicola L Cowley; Sarah Forbes; Alejandro Amézquita; Peter McClure; Gavin J Humphreys; Andrew J McBain
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

2.  Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus.

Authors:  Sarah Forbes; Joe Latimer; Abdulrahman Bazaid; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

3.  Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan.

Authors:  Marco Rinaldo Oggioni; Maria Laura Ciusa; Leonardo Furi; Lucilla Baldassarri; Graziella Orefici; Daniela Cirasola; Jose Luis Martinez; Ian Morrissey; Elisa Borghi
Journal:  Antimicrob Agents Chemother       Date:  2012-11       Impact factor: 5.191

4.  Triclosan-induced aminoglycoside-tolerant Listeria monocytogenes isolates can appear as small-colony variants.

Authors:  Vicky G Kastbjerg; Line Hein-Kristensen; Lone Gram
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 5.  Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.

Authors:  Barbara C Kahl; Karsten Becker; Bettina Löffler
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

6.  Profiling of Virulence Determinants in Cronobacter sakazakii Isolates from Different Plant and Environmental Commodities.

Authors:  Niharika Singh; Mamta Raghav; Shifa Narula; Simran Tandon; Gunjan Goel
Journal:  Curr Microbiol       Date:  2017-03-03       Impact factor: 2.188

7.  Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.

Authors:  Tatiana Johnston; Gabriel Lambert Hendricks; Steven Shen; Roy Fangxing Chen; Bumsup Kwon; Michael John Kelso; Wooseong Kim; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-09-21       Impact factor: 3.808

8.  Small colony variants have a major role in stability and persistence of Staphylococcus aureus biofilms.

Authors:  Zulfiqar Ali Mirani; Mubashir Aziz; Seema Ismat Khan
Journal:  J Antibiot (Tokyo)       Date:  2014-08-27       Impact factor: 2.649

9.  Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus.

Authors:  Leonardo Furi; Maria Laura Ciusa; Daniel Knight; Valeria Di Lorenzo; Nadia Tocci; Daniela Cirasola; Lluis Aragones; Joana Rosado Coelho; Ana Teresa Freitas; Emmanuela Marchi; Laura Moce; Pilar Visa; John Blackman Northwood; Carlo Viti; Elisa Borghi; Graziella Orefici; Ian Morrissey; Marco Rinaldo Oggioni
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

10.  Secretome analysis defines the major role of SecDF in Staphylococcus aureus virulence.

Authors:  Chantal Quiblier; Kati Seidl; Bernd Roschitzki; Annelies S Zinkernagel; Brigitte Berger-Bächi; Maria M Senn
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.